Treatment Procedures:
Medications: Medications such as hydroxyurea, L-glutamine, and crizanlizumab are used
to reduce the frequency of painful crises, decrease the risk of complications, and improve overall
outcomes in patients with sickle cell anemia.
Blood Transfusions: Red blood cell transfusions may be used to increase the number of
healthy red blood cells in circulation, improve oxygen delivery to tissues, and prevent
complications such as stroke or acute chest syndrome.
Hydroxyurea Therapy: Hydroxyurea is a medication that stimulates the production of
fetal hemoglobin, which has a higher affinity for oxygen and can help prevent sickle cell crises and
reduce the frequency of hospitalizations.
Bone Marrow Transplantation: For eligible patients with severe sickle cell anemia or
complications refractory to other treatments, bone marrow transplantation or stem cell
transplantation may be considered to replace diseased bone marrow with healthy stem cells and
potentially cure the disease.
Supportive Care Measures: Supportive care measures, including pain management,
hydration, nutritional support, and psychosocial support, play a crucial role in managing symptoms,
preventing complications, and improving overall well-being in patients with sickle cell anemia.